Type 2 Diabetes

Protocol

NN4506

Research Study Summary

The research study SUSTAIN FORTE is comparting 2 doses of the same diabetes medicines-semaglutide, which is sold as Ozempic.

Eligibility

Inclusion Criteria:

You may qualify if you:

  • are 18 years or older
  • have type 2 diabetes
  • have received metformin with or without sulphonlyurea for at least 90 days
  • are able to come to 9 clinic visits and have 2 phone calls over 49 weeks
Exclusion Criteria:

Additional Information:

You are compensated $50/completed clinic visit which is payable to you at the end of each visit.

Study Location

Clinical Investigations of Texas
1524 Independence Parkway
Suite M
Plano, Texas 75075
theresa.mueller@citplano.com

Contact Number

972-599-1530 ext. 9725991530

If you're interested in learning more about this study, complete the form below: